Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Thursday Feb 23, 2023
Thursday Feb 23, 2023
touchMDT for touchONCOLOGY
A medical oncologist, advanced practice nurse and patient advocate share their views on how the multidisciplinary team can support patients with HER2-positive colorectal cancer.
The multidisciplinary team:
- Medical oncologist: Dr Kristen Ciombor, Vanderbilt University Medical Center, Nashville, TN, USA
- Advanced practice nurse: Dr Kelley Rone, Mayo Clinic, Phoenix, AZ, USA
- Patient advocate: Mr Scott Wilson, Denver, CO, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Seagen Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/
Thursday Feb 23, 2023
Thursday Feb 23, 2023
touchMDT for touchONCOLOGY
Two medical oncologists discuss the latest clinical trial data for HER2-targeted treatments in colorectal cancer (CRC), how they utilize these agents in clinical practice, and what the future holds for HER2-targeting in CRC.
The multidisciplinary team:
- Medical oncologists: Dr Kristen Ciombor, Nashville, TN, USA and Prof. Andrea Sartore-Bianchi, Milan, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Seagen Inc. and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-perspectives-on-management-of-her2-crc/
Monday Feb 20, 2023
Monday Feb 20, 2023
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the emerging role of antibody-drug conjugates (ADCs) in the treatment of patients with non-small cell lung cancer (NSCLC), including the mechanistic rationale and role of biomarkers in patient selection, the latest efficacy and safety data, and dose-finding strategies for optimal use in NSCLC.
The experts:
- Prof. Jarushka Naidoo, Beaumont RCSI Cancer Centre, Dublin, Ireland
- Dr Rebecca Heist, Massachusetts General Hospital Cancer Center, Boston, MA, USA
- Dr Antonio Passaro, European Institute of Oncology, Milan, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is provided by touchIME.
For further information please visit: https://touchoncology.com/education/pd-navigating-the-nsclc-treatment-pathway-focus-on-adcs/
Tuesday Feb 14, 2023
Tuesday Feb 14, 2023
touchTALKS for touchONCOLOGY
Listen to a leading expert in higher-risk myelodysplastic neoplasms (HR-MDS) discuss the impact that emerging treatment options may have on clinical practice. Dr David Sallman covers the latest updates to the classification of HR-MDS, the mode of action of emerging therapeutic agents and the most recent clinical evidence on their efficacy and safety.
The expert:
- Dr David Sallman, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/hr-mds-emerging-treatments/
Monday Feb 13, 2023
Monday Feb 13, 2023
touchMDT for touchRESPIRATORY
Listen to key experts from a multidisciplinary team and a patient advocate discuss how to optimize long-term outcomes for children with severe asthma.
The multidisciplinary team
- Paediatric immunologist: Dr Wanda Phipatanakul
- Primary care physician: Dr Ioanna Tsiligianni
- Specialist asthma nurse: Ms Viv Marsh
- Patient advocate: Ms Monique Cooper
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchrespiratoryime.org/mdt-severe-paediatric-asthma
Monday Feb 13, 2023
Monday Feb 13, 2023
touchMDT for touchIMMUNOLOGY
Listen to key experts from a multidisciplinary team and a patient advocate discuss how to optimize long-term outcomes for children with severe asthma.
The multidisciplinary team:
- Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
- Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece
- Specialist asthma nurse: Ms Viv Marsh, Dudley Respiratory Group, West Midlands, UK
- Patient advocate: Ms Monique Cooper, Miami, FL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information please visit: https://touchimmunologyime.org/mdt-severe-paediatric-asthma
Monday Feb 13, 2023
Monday Feb 13, 2023
touchMDT for touchRESPIRATORY
Listen to key experts from a multidisciplinary team discuss strategies to monitor and support children with severe asthma.
The multidisciplinary team
- Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK
- Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
- Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece
- Specialist asthma nurse: Ms Viv Marsh, Dudley Respiratory Group, West Midlands, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information please visit: https://touchrespiratoryime.org/mdt-severe-paediatric-asthma
Monday Feb 13, 2023
Monday Feb 13, 2023
touchMDT for touchIMMUNOLOGY
Listen to key experts from a multidisciplinary team discuss strategies to monitor and support children with severe asthma.
The multidisciplinary team:
- Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK
- Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
- Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece
- Specialist asthma nurse: Ms Viv Marsh, Dudley Respiratory Group, West Midlands, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information please visit: https://touchimmunologyime.org/mdt-severe-paediatric-asthma
Monday Feb 13, 2023
Monday Feb 13, 2023
touchMDT for touchRESPIRATORY
Listen to key experts from a multidisciplinary team and a patient advocate discuss the use of biologics in the treatment of severe paediatric asthma, and how to support families when initiating treatment.
The multidisciplinary team:
- Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK
- Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
- Patient advocate: Ms Monique Cooper, Miami, FL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information please visit: https://touchrespiratoryime.org/mdt-severe-paediatric-asthma
Monday Feb 13, 2023
Monday Feb 13, 2023
touchMDT for touchIMMUNOLOGY
Listen to key experts from a multidisciplinary team and a patient advocate discuss the use of biologics in the treatment of severe paediatric asthma, and how to support families when initiating treatment.
The multidisciplinary team:
- Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK
- Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA
- Patient advocate: Ms Monique Cooper, Miami, FL, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information please visit: https://touchimmunologyime.org/mdt-severe-paediatric-asthma